Published in Urology on July 01, 2003
The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine. J Cancer Res Clin Oncol (2007) 0.81
Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2012) 9.88
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst (2005) 2.23
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clin J Am Soc Nephrol (2011) 1.63
Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J Clin Invest (2005) 1.46
Feasibility and accuracy of computational robot-assisted partial nephrectomy planning by virtual partial nephrectomy analysis. Int J Urol (2015) 1.44
Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer. Int J Urol (2015) 1.43
Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet (2002) 1.43
Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy. Can J Urol (2014) 1.40
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis (2011) 1.39
Initial operative experience of single-port retroperitoneal laparoscopic nephrectomy. Int J Urol (2012) 1.39
Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol (2008) 1.36
Prostate Cancer Working Group report. Jpn J Clin Oncol (2010) 1.25
Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J Urol (2003) 1.18
Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol (2009) 1.15
Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002. Int J Urol (2007) 1.14
The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2011) 1.12
Laxity of the vaginal introitus after childbirth: nonsurgical outpatient procedure for vaginal tissue restoration and improved sexual satisfaction using low-energy radiofrequency thermal therapy. J Womens Health (Larchmt) (2013) 1.11
Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management. Prostate Int (2014) 1.08
Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global study. J Endourol (2011) 1.07
3' Phosphatase activity toward phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] by voltage-sensing phosphatase (VSP). Proc Natl Acad Sci U S A (2012) 1.07
Lack of a laterality phenotype in Pkd1 knock-out embryos correlates with absence of polycystin-1 in nodal cilia. Differentiation (2005) 1.07
Amino acid transporter LAT3 is required for podocyte development and function. J Am Soc Nephrol (2009) 1.06
Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int (2004) 1.04
Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol (2002) 1.03
Incidentally discovered adrenal myelolipoma associated with hyperthyroidism. Int J Clin Oncol (2007) 1.00
Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. Urology (2010) 0.99
Age as a limiting factor for successful sperm retrieval in patients with nonmosaic Klinefelter's syndrome. Fertil Steril (2005) 0.98
Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res (2003) 0.98
Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer. Int J Urol (2010) 0.97
PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice. J Am Soc Nephrol (2007) 0.97
Laparoscopic management of urachal remnants in adulthood. Int J Urol (2006) 0.96
Stone attenuation value and cross-sectional area on computed tomography predict the success of shock wave lithotripsy. Korean J Urol (2013) 0.96
Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells. Biochem Biophys Res Commun (2007) 0.96
FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Anticancer Res (2007) 0.95
Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. Lab Invest (2011) 0.94
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate (2010) 0.94
Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease. Nephron Clin Pract (2005) 0.94
Prostatic cyst arising around the bladder neck-cause of bladder outlet obstruction: two case reports. Hinyokika Kiyo (2007) 0.92
Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy. Int J Urol (2006) 0.91
[Comparison of clinical results between TUR-P and holmium laser enucleation of the prostate (HoLEP) based on the initial experience]. Nihon Hinyokika Gakkai Zasshi (2008) 0.91
The impact of the Great Tohoku Earthquake on the dialysis practice in the disaster-stricken area. Hemodial Int (2011) 0.90
Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster. Cancer Sci (2007) 0.89
New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med (2005) 0.88
Renal disease progression in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2012) 0.88
Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis. Hum Cell (2008) 0.88
Kidney volume and function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2013) 0.87
Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer. Int J Urol (2010) 0.87
Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen. Cancer Sci (2011) 0.87
A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells. J Urol (2007) 0.86
The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD. Nephrol Dial Transplant (2008) 0.86
Urothelial carcinoma of the prostate. Urology (2007) 0.86
Enumeration of bacterial cell numbers and detection of significant bacteriuria by use of a new flow cytometry-based device. J Clin Microbiol (2006) 0.86
Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations. Urology (2002) 0.85
Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrol Dial Transplant (2009) 0.85
Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels. Anticancer Res (2008) 0.85
Overactive bladder symptom severity is associated with falls in community-dwelling adults: LOHAS study. BMJ Open (2013) 0.85
Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience. Int J Urol (2010) 0.85
Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. Hum Gene Ther (2007) 0.84
Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients. Int J Urol (2004) 0.84
Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer. Anticancer Res (2008) 0.84
PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta. Pflugers Arch (2008) 0.83
Hematuria: definition and screening test methods. Int J Urol (2008) 0.83
Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer. Prostate Int (2013) 0.83
Reinforcement of suspensory ligaments under local anesthesia cures pelvic organ prolapse: 12-month results. Int Urogynecol J (2013) 0.82
Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer. J Urol (2004) 0.81
Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse. Int J Cancer (2008) 0.80
Clinical practice manual for late-onset hypogonadism syndrome. Int J Urol (2008) 0.80
Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Int J Urol (2006) 0.80
Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer. Int J Urol (2009) 0.80
Evaluation of 2,590 urological laparoscopic surgeries undertaken by urological surgeons accredited by an endoscopic surgical skill qualification system in urological laparoscopy in Japan. Surg Endosc (2011) 0.80
Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease. Nephron (2015) 0.80